The Impact of PM+For Moms Intervention on Improving Mother's Mental Health in Zambia (PM+FM) (PM+FM)

April 29, 2024 updated by: Irene Falgas Bague, Swiss Tropical & Public Health Institute

CMHD are particularly prevalent among women, posing a major threat to their own and their children's wellbeing.

Despite the high prevalence of CMHD and the existence of effective treatments, interventions supporting women living in low-resourced settings remain limited.

This study builds on a parent study (Zamcharts NCT03991182), which identified a high prevalence of women with anxiety and/or depression. We propose to design, test, and validate a community-based intervention nested within the public primary health system in Zambia, to identify and treat women with mild-to-severe CMHDs.

Study Overview

Study Type

Interventional

Enrollment (Actual)

270

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lusaka, Zambia
        • Innovatations for Poverty Action

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Women participating in ZamCharts parent study
  • SRQ-20 >7 (clinically significant symptoms of depression or/anxiety),
  • not planning to move within the next 6 months,
  • with capacity to consent
  • not receiving current mental health care.

Exclusion Criteria:

  • Women with active suicidal ideation (determined by Paykel=4 OR 5),
  • severe substance use (ACOK-SUD >4),
  • mania or psychotic symptoms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Psychosocial intervention conducted by a trained Wellbeing-Community health worker. Adapted from Problem Management +, thinking healthy and Strong Minds-Strong Communities intervention to target women with small children and mental health symptoms living in low-resourced settings. Combines several evidence-based strategies such us psychoeducational, motivational interviewing, cognitive restructuring and relaxation exercises. Organized in 10 weekly sessions (8 individual 2 in group) provided in-person, by phone or virtually.
No Intervention: Usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Mental health symptoms. SRQ-20
Time Frame: Change between Baseline (at enrollment) and 6 months after enrollment
20 items measuring risk of common mental health problem.
Change between Baseline (at enrollment) and 6 months after enrollment
Feasibility of the study
Time Frame: Assessed 4 months after enrollment
% of 1 or more sessions completed. Qualitative feedback from participants and providers.
Assessed 4 months after enrollment
Acceptability
Time Frame: Assessed 4 months after enrollment
% of participants completing more than 6 sessions. Qualitative feedback from participants and providers.
Assessed 4 months after enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Anxiety and Depression symptoms.
Time Frame: Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment
HSCL-25. 10 questions anxiety, 15 depression; (α = 0.90).
Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment
Change in Mental health symptoms. PSYCHLOPS
Time Frame: Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment
Psychological Outcome Profiles (5 items)
Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment
Functionality
Time Frame: Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment
WHO-DAS2
Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment
World Bank's Toolkit and Inventory
Time Frame: Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment
Selected measures from the World Bank Toolkit to address mother-child interactions and child early development.
Used for the pre-post treatment analysis. Change between Baseline (at enrollment) and 4 months after enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2022

Primary Completion (Actual)

October 1, 2023

Study Completion (Actual)

December 1, 2023

Study Registration Dates

First Submitted

November 7, 2022

First Submitted That Met QC Criteria

November 23, 2022

First Posted (Actual)

November 25, 2022

Study Record Updates

Last Update Posted (Actual)

April 30, 2024

Last Update Submitted That Met QC Criteria

April 29, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Problem Management + For Moms

Subscribe